NCT03167307 - The Omega-3 Fatty Acid Paediatric Depression Trial | Biotech Hunter

Enrollment

257

Participants

Timeline

Start Date

April 28, 2017

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions

Depression

Interventions

DRUG

Omega 3 fatty acid

Omega-3 fatty acids in addition to standard treatment for depression in children and adolescents according to the German S3 Guidelines

DRUG

Placebo oil

medium chain triglycerides in addition to standard treatment for depression in children and adolescents according to the German S3 Guidelines

Trial Locations (7)

Psychiatric University Clinics, Department of Child and Adolescent Psychiatry, Zurich

Psychiatric Services Baselland, Liestal

Klinik Sonnenhof, Ganterschwil

Clienia Littenheid, Littenheid

Spital Thurgau Kinder- und Jugendpsychiatrischer Dienst, Weinfelden

University Psychiatric Services, Basel

Stiftung Kinder- und Jugendpsychiatrische Dienste St.Gallen, Sankt Gallen

All Listed Sponsors

collaborator

Swiss National Science Foundation

OTHER

lead

Gregor Berger

OTHER